H Diem - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

H Diem

Showing results (21-30 of 22) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 22 results.

Annals of Hematology|February 1, 1997

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expressionV Nüssler, F Gieseler, H Zwierzina, et al.

Leukemia|April 9, 2004

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)C-M Wendtner, M Ritgen, C D Schweighofer, et al.

Pageof 3

Search research articles

Showing results (21-30 of 22) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 22 results.

Annals of Hematology|February 1, 1997

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expressionV Nüssler, F Gieseler, H Zwierzina, et al.

Leukemia|April 9, 2004

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)C-M Wendtner, M Ritgen, C D Schweighofer, et al.

Pageof 3